https://esid.org

ESID - European Society for Immunodeficienciesimmunodeficiency, immunoglobulins, B cells, T cells, hypogammaglobulinemia, recurrent infections, phagocytosis, severe infections, diagnosisExchange of ideas and information among doctors, nurses, biomedical investigators, patients and their families concerned with primary immunodeficiency diseases (PID).ESID - European Society for Immunodeficiencies ESID members login Membership Become an ESID member and enjoy the following benefits: Access the ESID network of PID Reduced registration fees to the ESID biennial meeting Eligibility to apply to the ESID Summer SchoolEligibility to benefit from an ESID award And much more... Login Register More information Become an ESID member today! Forgot Your Password? Esid European Society for Immunodeficiencies Menu Members login E-mail Password Forgot Your Password? Search es About ESID es ESID Vision & Mission es ESID Board es General Assembly 2022 es ESID Articles of Association es ESID Constitution es ESID Society Information es ESID Policy Plan es Financial Information es ESID ANBI Forms es ESID Lifetime Achievement Award es Contact es First International Neonatal Screening Day es ESID 2024 Board Elections - Call for Candidates es International Neonatal Screening Day Event 29th of June 2022 es International Neonatal Screening Day 28th of June 2022 es ESID 2024 Board Elections - Meet the Candidates es News & Events es Message from President es Scientific meetings es Newsletter es Jobs in PID es ESID Meetings es Focused Meetings es ESID Biennial Meeting es Past News es Funding & Awards es Events es Working Parties es Clinical Working Party es Studies es News & Events es Resources es Grand Rounds 2021-2024 es Statements es Education Working Party es Events es Resources es Reports es Funding & Awards es ESID Support to other Educational Activities es Genetics Working Party es News & Events es Resources es Current topics es Inborn Errors Working Party (IEWP) es Studies es News & Events es Resources es Juniors Working Party es Centers for fellowship es Facebook link es News es Events es Funding & Awards es Upcoming Online Sessions es Archived Online Sessions es Call for Candidates for Junior Country Representatives Term 2024-2026 es Country Representatives es ESID Juniors Educational Video Series es Call for Presenters 2024 es ESID GenIA call for curators es 2024 Elections - Junior Country Representatives - Meet the Candidates es PID Care in Development Working Party es Events es News es J Project es Registry Working Party es ESID Registry es Reporting website es Diagnosis criteria es Registry publications es Studies es News and Events es Documenting centers es Old Registry Stats es Informed Patient Consent es Contact info es Membership es My ESID Membership Profile es International Alliance for PIDs es NEW! ESID Complimentary Membership Grants es Renew my membership es Join ESID es ESID Members Directory es ESID Junior Members Directory es Journal of Clinical Immunology es Privacy and cookies policy es Education es Documents/Reports es Call for studies es Interesting papers in PID es Links es COVID-19 Home About ESID ESID Vision & Mission ESID Board General Assembly 2022 ESID Articles of Association ESID Constitution ESID Society Information ESID Policy Plan Financial Information ESID ANBI Forms ESID Lifetime Achievement Award Contact First International Neonatal Screening Day ESID 2024 Board Elections - Call for Candidates International Neonatal Screening Day Event 29th of June 2022 International Neonatal Screening Day 28th of June 2022 ESID 2024 Board Elections - Meet the Candidates Dear Friends and Colleagues ESID Members,   It was wonderful meeting so many of you at the past Lisbon 2018 Biannual Meeting which was a tremendous success. We could count 2470 participants from 92 countries. 855 abstracts had been submitted. I would like to sincerely thank the entire Portugese organising committee with Joao Neves, Ana Cordeiro and José Gonçalo Marques  as well as the international scientific committee and the ESID board, who prepared an exciting scientific and clinical program from the educational day and keynote lecture to the late breaker session.  It was also moving to see Prof. Claude Griscelli honoured with the ESID lifetime achievement award and applauded in a standing ovation. No meeting is perfect however, no speakers’ and chairs’ distribution completely in balance and I have listened and will continue to listen to your suggestions to do even better at the focused meeting in Brussels 2019 and at the biannual meeting 2020 in Birmingham.  I also wish to express my sincere gratitude to the many ESID Members who have shown their engagement and commitment for our society by running for an opening WP Chair function during the past elections. I am confident that you will be able to engage in the mission of ESID regardless of the election results. At the same time I thank the outgoing board members for their great passion and commitment: thank you Eleonora Gambineri, thank you Peter Olbrich, Peter Jandus, Kaan Boztug and Nizar Mahlaoui. You will be missed but not forgotten. I welcome Anne Puel as Genetics WP Chair, Clara Franco as Junior WP Chair, Joao Neves as PID in Development Chair, Despina Moshous as Educational WP Chair and Mikko Seppänen as the Registry WP Chair. I look very much forward to working with you and I applaud the growing diversity in country representation in our board. I am happy to be able to count on the continuous support and efforts of Andy Gennery, Arjan Lankester, Mirjam Van Der Burg, Fabio Candotti and outgoing president Andrew Cant as my co-pilots in this undertaking.   As your new President, I will give it my best effort to navigate ESID through the changing waters of a growing society with many questions and challenges ahead while never forgetting our mission statement: “ESID believes that every child, adolescent and adult born with a defective immune system has the right to benefit from both clinical and scientific knowledge. Therefore, our mission is to enable patients with primary immunodeficiency diseases to live their lives to its full potential by improving awareness, diagnosis, treatment, education and understanding of these diseases. ESID is committed to promote collaboration between healthcare professionals, patient organisations, industry and governmental bodies and to foster education and research.” Let us continue changing the lives of those affected by primary immunodeficiency, throughout Europe, and beyond.  Do not hesitate to voice your opinion, ideas and suggestions. Thank you for your trust.   Isabelle Meyts    Prof. Isabelle Meyts Past-President (2022-2024) News & Events Message from President Scientific meetings Newsletter Jobs in PID ESID Meetings Past News Funding & Awards Events In Focus In focus Joint statement on the current epidemics of new Coronavirus Mar 11, 2020 es IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic Nov 04, 2021 es ESID COVID-19 Statement, March 2022 Sep 09, 2013 es Working Parties Clinical Working Party Education Working Party Genetics Working Party Inborn Errors Working Party (IEWP) Juniors Working Party PID Care in Development Working Party Registry Working Party Membership My ESID Membership Profile International Alliance for PIDs NEW! ESID Complimentary Membership Grants Renew my membership Join ESID ESID Members Directory ESID Junior Members Directory Journal of Clinical Immunology Privacy and cookies policy Education Documents/Reports Call for studies Interesting papers in PID Links COVID-19 . . more information . . more information . . more information ESID Call for Presenters 2024 . more information ESID 2024 Board Elections - Call for Candidates Call for Candidates more information In Focus Joint statement on the current epidemics of new Coronavirus Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on... es IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic  IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antib... es ESID COVID-19 Statement, March 2022 Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) p... es News Optimizing transplantation of inborn errors of immunity ... es ESID Summer School 2024 - News! An exciting opportunity for ESID Juniors - Registrations are now open for the ESID 2... es Job opportunity for PhD graduates and experienced scientists at NCMM in Oslo! ... es Events Grand Rounds Webinar May 2022: STOP XLA - Recording is available here es ESID Grand Rounds 2021-2022 - Round 2: Managing COVID in patients with Type 1 IFN pathway defects - Video es Shortcuts Affiliated Societies es ESID 2024 Biennial meeting in Marseille es Access the Grand Rounds Webinars' recordings here es ESID Online Registry es Access ESID’s latest news es Home About ESID Site Map Privacy Notice Contact Imprint & Disclaimer | © 2024 by European Society for Immunodeficiencies (ESID). All rights reserved. Designed by ZWEBB | powered by eZ Publish™nbnb1730130181https://esid.org

Fa'atonu lau saite?

O au mea na e fai?